Clinical Trials at the CCCC
Clinical trials are a very important instrument for the continuous development of medical progress and improved
improved quality of care.
They serve both the clinical testing of newly developed drugs or forms of treatment and the comparative review of already established treatment procedures.
You are here:
Further information for patients and physicians about the possibilities of participating in clinical trials at the CCCC.
In the sections below, you will find information on the studies currently being conducted by the individual clinics of the Tumor Centers
If available, a file is attached to the studies with
a brief descripition of the study, with the most important inclusion and exclusion criteria as well as the contact persons.
You can either contact the responsible contact person directly or call our hotline for more information:
Please select the relevant area here
Clinical Trials at Charité - Get an overview of all clinical trials at Charité.
More than 800 clinical trials in a wide variety of indications are conducted each year at Charité - Universitätsmedizin Berlin. The majority of these studies are initiated and conducted by Charité scientists (IIT, Investigator Initiated Trial), for which third-party funding is obtained from public sponsors (BMBF, DFG, EU), foundations and industrial partners. In addition, the research location Charité is an attractive partner for companies in the pharmaceutical industry, manufacturers of medical devices and biotechnology (contract research).
Click here to visit the website of the clinical trials at Charité.
Learn more about the Central Stukuren Clinical Trials and the quality assurance by the Quality Assurance Unit Clinical Trials here.
Supraregional, Central Study Registry of German Cancer Consortium for Translational Cancer Research
Oncological therapy studies that are open to patients in Germany at our Charité Comprehensive Cancer Center or at one of the other German cancer centers and partners of the DKTK can be found quickly, easily and specifically via the DKTK study registry. The registry offers a convenient search by selecting oncological focus, molecular markers, lines of therapy and participating hospitals in the DKTK. Study information can be downloaded, printed, or saved. The fact sheet also provides contact details at clinics and links to local study registries and other websites, which in turn provide more detailed information.
To access the DKTK study registry and an overview of participating partners, click here.
